159 related articles for article (PubMed ID: 1865630)
1. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
Schölkens BA; Linz W
Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
[TBL] [Abstract][Full Text] [Related]
2. Local inhibition of bradykinin degradation in ischemic hearts.
Linz W; Martorana PA; Schölkens BA
J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
[TBL] [Abstract][Full Text] [Related]
3. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Z Kardiol; 1994; 83 Suppl 4():53-6. PubMed ID: 7856280
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
Schölkens BA; Linz W
Clin Physiol Biochem; 1990; 8 Suppl 1():33-43. PubMed ID: 2147878
[TBL] [Abstract][Full Text] [Related]
5. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril.
Linz W; Schölkens BA; Kaiser J; Just M; Qi BY; Albus U; Petry P
Cardiovasc Drugs Ther; 1989 Dec; 3(6):873-82. PubMed ID: 2535056
[TBL] [Abstract][Full Text] [Related]
6. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist.
Schölkens BA; Linz W; König W
J Hypertens Suppl; 1988 Dec; 6(4):S25-8. PubMed ID: 2853732
[TBL] [Abstract][Full Text] [Related]
7. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
Freise H; Palmes D; Spiegel HU
J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
[TBL] [Abstract][Full Text] [Related]
9. Local inhibition of angiotensin II formation and bradykinin degradation in isolated hearts.
Schölkens BA; Linz W
Clin Exp Hypertens A; 1988; 10(6):1259-70. PubMed ID: 2975971
[TBL] [Abstract][Full Text] [Related]
10. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
[TBL] [Abstract][Full Text] [Related]
11. Influence of local converting enzyme inhibition on angiotensin and bradykinin effects in ischemic rat hearts.
Linz W; Schölkens BA
J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S75-82. PubMed ID: 2485067
[TBL] [Abstract][Full Text] [Related]
12. The possible role of bradykinin in the antiischemic activity of ACE-inhibitors.
Martorana PA; Schölkens BA
Agents Actions Suppl; 1992; 38 ( Pt 3)():98-102. PubMed ID: 1462888
[TBL] [Abstract][Full Text] [Related]
13. Experimental cardiovascular benefits of angiotensin-converting enzyme inhibitors: beyond blood pressure reduction.
Schölkens BA; Linz W; Martorana PA
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S26-30. PubMed ID: 1725038
[TBL] [Abstract][Full Text] [Related]
14. [Reduction of infarct size and remodeling after ramipril].
Martorana PA; Linz W; Schölkens BA
Z Kardiol; 1994; 83 Suppl 4():63-4. PubMed ID: 7856282
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: mediated by endogenous bradykinin?
Shimada Y; Avkiran M
J Cardiovasc Pharmacol; 1996 Mar; 27(3):428-38. PubMed ID: 8907806
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of angiotensin I converting enzyme inhibitor on post-ischemic contractile function of perfused rat heart.
Tanonaka K; Kamiyama T; Takezono A; Sakai K; Takeo S
J Mol Cell Cardiol; 1996 Aug; 28(8):1659-70. PubMed ID: 8877776
[TBL] [Abstract][Full Text] [Related]
17. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
Linz W; Lau HH; Beck G; Schökens BA
Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin-mediated metabolic effects in isolated perfused rat hearts.
Schoelkens BA; Linz W
Agents Actions Suppl; 1992; 38 ( Pt 2)():36-42. PubMed ID: 1462841
[TBL] [Abstract][Full Text] [Related]
19. The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Rastegar MA; Marchini F; Morazzoni G; Vegh A; Papp JG; Parratt JR
Br J Pharmacol; 2000 Feb; 129(4):671-80. PubMed ID: 10683191
[TBL] [Abstract][Full Text] [Related]
20. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA.
Chen H; Mohuczy D; Li D; Kimura B; Phillips MI; Mehta P; Mehta JL
Gene Ther; 2001 May; 8(10):804-10. PubMed ID: 11420645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
